News & Updates

Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
09 Nov 2022

Patients with severe obesity and nonalcoholic fatty liver disease (NAFLD) appear to benefit from bariatric surgery, which significantly reduces the risk of cardiovascular disease (CVD), a study has found.

Bariatric surgery provides cardioprotection in patients with severe obesity, NAFLD
09 Nov 2022
Menopause occurs early among women with diabetes
Menopause occurs early among women with diabetes
09 Nov 2022
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022 byJairia Dela Cruz

Patients with concomitant chronic kidney disease (CKD) and type 2 diabetes (T2D) who are undergoing mineralocorticoid receptor blockade with finerenone are better protected against pneumonia and COVID-19, according to a secondary analysis of data from the FIDELITY trials.

Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
01 Nov 2022
4 anti-obesity meds: AGA top picks
4 anti-obesity meds: AGA top picks
01 Nov 2022 byElvira Manzano

Obese adults with weight-related complications who do not respond adequately to lifestyle interventions should be offered one of four anti-obesity medications, according to the new clinical practice guideline on pharmacological interventions released by the American Gastroenterological Association (AGA).

4 anti-obesity meds: AGA top picks
01 Nov 2022